rha

[السفير]

كان المفروض ادخل عند 1.54
بس مالحقت
وقاعد اطارد فيها وماقدرت ادخل
الان 1.79 ومتردد
بين 1.55 و1.57
كان شراء ضخم عليها بالخمسين والمائة الف
بل واحد اشترى اكثر من نصف مليون على 1.73

[بن فهد]

هلا اخي الغالي السفير هلا بالجميع
rha وين رايحه ؟؟؟!!!
اخوكم
ومحبكم
حنون

[بن فهد]

هلا
شكلها بتنزل خبر يوم الاثنين والله اعلم

[بن فهد]

وهذا الخبر نزل شباب انتبهوا للخبر فيه شيء للي متابع هذه الشركه يفيدنا الدعوه افلاس شغلات الحذر
شباب
PARIS (Dow Jones)--When investors are turning increasingly bullish on one of the ugliest ducklings of Europe's chemicals sector, then it's time for everyone to sit up and take note.

There are increasingly convincing signs that the recent run-up in shares in Rhodia, the French company that narrowly staved off bankruptcy in 2003, isn't just a speculative punt based on the righting of the company's finances and faster-than-expected restructuring under new management.

As CEO Jean-Pierre Clamadieu told a French newspaper Monday, what's new at Rhodia is the company's success in raising its prices thanks to strong demand in the U.S. and Asia - which at the very least offsets the continued impact of high raw material costs as crude oil prices hover near $50 a barrel.

Given the false dawns at Rhodia in recent years, normally comments like these by one of its executives would be taken with a pinch of salt.

But there's mounting evidence to support Clamadieu's view as companies across the chemicals sector in the U.S., Europe and Asia are pushing through price increases for many, if not all, of their products. Take recent announcements by Albermarle Corp., BASF, Dow Chemical, Degussa, and Sumitomo Chemical as evidence.

Then there are the sharp recent month-on-month rises in the prices of materials from benzene to ethylene, styrene, low density polyethylene resins and fibers such as xylenes and nylon.

Of course, this is hardly the sudden discovery of a fundamental shift in investor sentiment - it's clear the train is leaving the station. There have been bullish assessments of the sector by analysts at J.P. Morgan and Citigroup in the past week. Meanwhile, privately held U.S. ethylene and propylene producer Huntsman has said it's planning an IPO this quarter, while Cytec Industries paid a full price last week for the chemicals business of Belgium's UCB.

To be sure, many chemicals companies are ramping up capacity to meet strong demand, particularly in China, which will ultimately bring supply and demand back into balance, though perhaps not in 2005.

And there's the major caveat that much hinges on oil prices, given that rising input costs have in large part contributed to the "exceptionally long trough" - to use Clamadieu's words - in the industry.

If crude oil prices climb above $50 a barrel, chemicals producers will feel the squeeze again, not only in terms of margins but also the higher risk of a hard landing for the global economy. But if, as is perhaps more likely, oil prices at the very worst remain buoyant around $40 in the short-to-medium term,then margins could continue to improve.

That's perhaps a reason for sticking with the diversified oil majors like BP and Total, if you suspect oil prices are peaking, highly valued though they are. Their petrochemical operations could pick up some of the slack from subsiding crude oil prices.

As for investors eyeing European chemicals companies, they have a choice between the lower-risk pure plays of a BASF or DSM or the more leveraged turnaround stories of a Rhodia, with diversified companies like Bayer and Akzo Nobel, or the lower-margin Clariant, perhaps the less attractive alternatives.

(Matthew Curtin has been a financial news reporter since 1990, and has reported on international finance and business for Dow Jones Newswires - from South Africa, Singapore and now Paris - since 1994. He can be reached at +331 4017 1740 or by e-mail: matthew.curtin@dowjones.com)

(END) Dow Jones Newswires

10-04-04 0741ET